Search

Search Constraints

You searched for: Author/Creator Isapof, Arnaud

Search Results

1. A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management. (19th February 2019)

2. Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data. (22nd March 2021)

3. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Issue 1 (December 2018)

4. Congenital immobility and stiffness related to biallelic ATAD1 variants. (December 2020)

5. De novo variants in TCF7L2 are associated with a syndromic neurodevelopmental disorder. Issue 8 (18th May 2021)

6. Evidence-Based, Implementable Motor Rehabilitation Guidelines for Individuals With Cerebral Palsy. (16th August 2022)

7. Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. Issue 8 (17th March 2016)

8. GGPS1‐associated muscular dystrophy with and without hearing loss. Issue 9 (23rd July 2022)

9. How chromosomal deletions can unmask recessive mutations? Deletions in 10q11.2 associated with CHAT or SLC18A3 mutations lead to congenital myasthenic syndrome. Issue 1 (12th November 2017)

10. JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study. (12th February 2021)